Thu. Dec 7th, 2023
    Johnson & Johnson MedTech Plans to Introduce Innovative Robotic Surgical System to U.S. Clinical Trials

    The OTTAVA™ System, developed by Johnson & Johnson MedTech, is set to revolutionize the field of surgery with its groundbreaking features and advanced design. The company has announced its intentions to submit the robotic surgical system for an investigational device exemption (IDE) application to the U.S. Food & Drug Administration (FDA) in the second half of 2024. This submission will mark the beginning of clinical trials for the system.

    With a legacy of over 135 years of leadership in surgery, Johnson & Johnson MedTech has introduced the OTTAVA system to reimagine the surgical experience. The system aims to create ample space in the operating room (OR), simplify complex workflows, allow for flexible clinical approaches, and provide the trusted performance of Ethicon** instrumentation.

    The OTTAVA system seamlessly integrates into the OR, offering an entirely new clinical experience. The system incorporates four robotic arms into a standard surgical table, creating an invisible design where the arms are hidden when not in use. The freedom of movement and collaboration in the operating room is enhanced, offering surgical teams the flexibility to adapt to different workflows and cater to individual patient needs.

    A notable feature of the OTTAVA system is its “twin motion” capability, enabling unified movement of both the table and the robotic arms. This innovative design allows surgical teams to address critical clinical needs during surgery, such as repositioning a patient without interrupting the procedure.

    By exclusively incorporating trusted Ethicon instrumentation, the OTTAVA system ensures consistency and precision during surgical procedures. Surgeons can expect a more streamlined experience, bridging the gap between traditional laparoscopic and robotic procedures.


    Q: What is the OTTAVA System?
    A: The OTTAVA System is a robotic surgical system developed by Johnson & Johnson MedTech.

    Q: When will the system undergo U.S. clinical trials?
    A: Johnson & Johnson MedTech plans to initiate U.S. clinical trials for the OTTAVA System in the second half of 2024.

    Q: How does the OTTAVA system integrate into the operating room?
    A: The OTTAVA system incorporates four robotic arms into a standard surgical table, allowing for seamless integration into the operating room.

    Q: What is the significance of the “twin motion” feature?
    A: The “twin motion” feature of the OTTAVA system enables simultaneous movement of the table and robotic arms, providing surgical teams with greater flexibility during procedures.

    Q: What is the advantage of using Ethicon instrumentation with the OTTAVA system?
    A: By utilizing Ethicon instrumentation, the OTTAVA system ensures consistency and precision in surgical procedures.

    ** Ethicon represents the products and services of Ethicon, Inc., and certain of their affiliates. All other trademarks are the property of their respective owners.